Literature DB >> 10666475

Functional coexpression of serine protein kinase SRPK1 and its substrate ASF/SF2 in Escherichia coli.

B G Yue1, P Ajuh, G Akusjärvi, A I Lamond, J P Kreivi.   

Abstract

Mammalian proteins expressed in Escherichia coli are used in a variety of applications. A major drawback in producing eukaryotic proteins in E.coli is that the bacteria lack most eukaryotic post-translational modification systems, including serine/threonine protein kinase(s). Here we show that a eukaryotic protein can be phosphorylated in E.coli by simultaneous expression of a mammalian protein kinase and its substrate. We show that in bacteria expressing SRPK1, ASF/SF2 becomes phosphorylated to a degree resembling native ASF/SF2 present in interphase HeLa cell nuclei. The E.coli phosphorylated ASF/SF2 is functional in splicing and, contrary to the unphosphorylated protein, soluble under native conditions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10666475      PMCID: PMC102625          DOI: 10.1093/nar/28.5.e14

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  15 in total

1.  SR proteins: a conserved family of pre-mRNA splicing factors.

Authors:  A M Zahler; W S Lane; J A Stolk; M B Roth
Journal:  Genes Dev       Date:  1992-05       Impact factor: 11.361

2.  Inhibition by SR proteins of splicing of a regulated adenovirus pre-mRNA.

Authors:  A Kanopka; O Mühlemann; G Akusjärvi
Journal:  Nature       Date:  1996-06-06       Impact factor: 49.962

3.  Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing.

Authors:  S H Xiao; J L Manley
Journal:  Genes Dev       Date:  1997-02-01       Impact factor: 11.361

4.  Purification and characterization of pre-mRNA splicing factor SF2 from HeLa cells.

Authors:  A R Krainer; G C Conway; D Kozak
Journal:  Genes Dev       Date:  1990-07       Impact factor: 11.361

5.  Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro.

Authors:  W Cao; S F Jamison; M A Garcia-Blanco
Journal:  RNA       Date:  1997-12       Impact factor: 4.942

6.  The essential pre-mRNA splicing factor SF2 influences 5' splice site selection by activating proximal sites.

Authors:  A R Krainer; G C Conway; D Kozak
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

7.  Novel SR-protein-specific kinase, SRPK2, disassembles nuclear speckles.

Authors:  N Kuroyanagi; H Onogi; T Wakabayashi; M Hagiwara
Journal:  Biochem Biophys Res Commun       Date:  1998-01-14       Impact factor: 3.575

8.  SRPK1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors.

Authors:  K Colwill; L L Feng; J M Yeakley; G D Gish; J F Cáceres; T Pawson; X D Fu
Journal:  J Biol Chem       Date:  1996-10-04       Impact factor: 5.157

9.  The Clk2 and Clk3 dual-specificity protein kinases regulate the intranuclear distribution of SR proteins and influence pre-mRNA splicing.

Authors:  P I Duncan; D F Stojdl; R M Marius; K H Scheit; J C Bell
Journal:  Exp Cell Res       Date:  1998-06-15       Impact factor: 3.905

10.  Regulation of mammalian spliceosome assembly by a protein phosphorylation mechanism.

Authors:  J E Mermoud; P T Cohen; A I Lamond
Journal:  EMBO J       Date:  1994-12-01       Impact factor: 11.598

View more
  12 in total

1.  The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.

Authors:  Vita Dauksaite; Göran Akusjärvi
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

2.  Phosphorylation by SR kinases regulates the binding of PTB-associated splicing factor (PSF) to the pre-mRNA polypyrimidine tract.

Authors:  Ching-Jung Huang; Zhaohua Tang; Ren-Jang Lin; Philip W Tucker
Journal:  FEBS Lett       Date:  2006-12-14       Impact factor: 4.124

Review 3.  Production of active eukaryotic proteins through bacterial expression systems: a review of the existing biotechnology strategies.

Authors:  Sudhir Sahdev; Sunil K Khattar; Kulvinder Singh Saini
Journal:  Mol Cell Biochem       Date:  2007-09-12       Impact factor: 3.396

4.  Protein interaction module-assisted function X (PIMAX) approach to producing challenging proteins including hyperphosphorylated tau and active CDK5/p25 kinase complex.

Authors:  Dexin Sui; Xinjing Xu; Xuemei Ye; Mengyu Liu; Maxwell Mianecki; Chotirat Rattanasinchai; Christopher Buehl; Xiexiong Deng; Min-Hao Kuo
Journal:  Mol Cell Proteomics       Date:  2014-11-10       Impact factor: 5.911

5.  U2AF65 assemblies drive sequence-specific splice site recognition.

Authors:  Manel Tari; Valérie Manceau; Jean de Matha Salone; Asaki Kobayashi; David Pastré; Alexandre Maucuer
Journal:  EMBO Rep       Date:  2019-07-04       Impact factor: 8.807

6.  Full-length hepatitis B virus core protein packages viral and heterologous RNA with similarly high levels of cooperativity.

Authors:  J Zachary Porterfield; Mary Savari Dhason; Daniel D Loeb; Michael Nassal; Stephen J Stray; Adam Zlotnick
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

7.  Production of active recombinant eIF5A: reconstitution in E.coli of eukaryotic hypusine modification of eIF5A by its coexpression with modifying enzymes.

Authors:  Jong Hwan Park; Camila A O Dias; Seung Bum Lee; Sandro R Valentini; Masaaki Sokabe; Christopher S Fraser; Myung Hee Park
Journal:  Protein Eng Des Sel       Date:  2010-12-02       Impact factor: 1.650

8.  RS domains contact splicing signals and promote splicing by a common mechanism in yeast through humans.

Authors:  Haihong Shen; Michael R Green
Journal:  Genes Dev       Date:  2006-06-09       Impact factor: 11.361

9.  A novel function of Arp2p in mediating Prk1p-specific regulation of actin and endocytosis in yeast.

Authors:  Mingji Jin; Mingjie Cai
Journal:  Mol Biol Cell       Date:  2007-10-31       Impact factor: 4.138

10.  The E1circumflexE4 protein of human papillomavirus interacts with the serine-arginine-specific protein kinase SRPK1.

Authors:  Ian Bell; Ashley Martin; Sally Roberts
Journal:  J Virol       Date:  2007-03-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.